North Star Investment Management’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5 | Hold |
17
| – | – | ﹤0.01% | 1212 |
|
|
2025
Q1 | $17 | Hold |
17
| – | – | ﹤0.01% | 1194 |
|
|
2024
Q4 | $29 | Hold |
17
| – | – | ﹤0.01% | 1211 |
|
|
2024
Q3 | $48 | Hold |
17
| – | – | ﹤0.01% | 1174 |
|
|
2024
Q2 | $60 | Buy |
17
+1
| +6% | +$4 | ﹤0.01% | 1150 |
|
|
2024
Q1 | $95 | Sell |
16
-1
| -6% | -$6 | ﹤0.01% | 1219 |
|
|
2023
Q4 | $215 | Hold |
17
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q3 | $107 | Hold |
17
| – | – | ﹤0.01% | 1254 |
|
|
2023
Q2 | $145 | Hold |
17
| – | – | ﹤0.01% | 1264 |
|
|
2023
Q1 | $240 | Hold |
17
| – | – | ﹤0.01% | 1267 |
|
|
2022
Q4 | $265 | Hold |
17
| – | – | ﹤0.01% | 1270 |
|
|
2022
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 1161 |
|
|
2022
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 1162 |
|
|
2022
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 1185 |
|
|
2021
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 1203 |
|
|
2021
Q3 | $1K | Hold |
17
| – | – | ﹤0.01% | 1082 |
|
|
2021
Q2 | $1K | Hold |
17
| – | – | ﹤0.01% | 1058 |
|
|
2021
Q1 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 1021 |
|